Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age

Clinical Endocrinology

Volumn 54, Issue 2, 2001, Pages 243-251

  Sas, Theo ^a   Mulder, Paul ^b   Aanstoot, Henk Jan ^c   Houdijk, Mieke ^d   Jansen, Maarten ^e   Reeser, Maarten ^f   Hokken Koelega, Anita ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c IJSSELLAND HOSPITAL   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f JULIANA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HUMAN GROWTH HORMONE; INSULIN;

AREA UNDER THE CURVE; ARTICLE; CARBOHYDRATE METABOLISM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HORMONAL THERAPY; HUMAN; HYPERINSULINISM; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL GLUCOSE TOLERANCE TEST; PREPUBERTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT STATURE; SMALL FOR DATE INFANT; TREATMENT OUTCOME;

AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CARBOHYDRATE METABOLISM; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH DISORDERS; GROWTH HORMONE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; MALE;

EID: 0035127773     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01178.x     Document Type: Article

References (34)

1. Growth and metabolic data following growth hormone treatment of children with intrauterine growth retardation
2. Natural growth in children born small for gestational age with and without catch-up growth
3. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth
4. Growth hormone treatment of short children born small-for-gestational-age: The Nordic Multicentre Trial
5. The effect of growth hormone on glucose metabolism and insulin secretion in man
6. Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth retarded children
7. Adult height in children with prepubertal short stature secondary to intra uterine growth retardation
8. Effects of growth hormone therapy in prepubertal children with short stature secondary to intrauterine growth retardation
9. Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action
10. Insulin resistance in short children with intrauterine growth retardation
11. Children born small for gestational age: Do they catch-up?
12. A placebocontrolled, double-blind trail in prepubertal children after renal transplant
13. Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset
14. Growth in full-term small-for-gestational-age infants: From birth to final height
15. Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency
16. Diabetogenic and hypoglycemia effects of human growth hormone
17. Pubertal changes in insulin secretion and peripheral insulin sensitivity
18. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes
19. Prepubertal height velocity references over a wide age range
20. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization
21. Growth diagrams 1980, Netherlands. Third nation-wide survey
22. Safety aspects of GH therapy in Turner syndrome (TS): No evidence for ventricular hypertrophy (VH) and normalization of insulin levels after discontinuation of GH
23. Growth hormone treatment in children with short stature born small for gestational age: Five-year results of a randomized, double-blind, dose-response trial
24. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response trial
25. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections
26. Longitudinal standards for height, weight-height, height velocity and stages of puberty
27. Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome
28. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
29. Intrauterine growth of liveborn caucasian infants at sea level: Standard obtained from measurements of infants born between 25 and 44 weeks of gestation
30. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation
31. Growth hormone treatment of short children born small for gestational age: Reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years
32. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: Results over 6 years
33. High-dose growth hormone treatment of short children born small for gestational age